wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33439312-50A022D7-2E7B-448E-B179-1EF0DCC938C2
Q33439312-50A022D7-2E7B-448E-B179-1EF0DCC938C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-50A022D7-2E7B-448E-B179-1EF0DCC938C2
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
P6179
Q33439312-50A022D7-2E7B-448E-B179-1EF0DCC938C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-50A022D7-2E7B-448E-B179-1EF0DCC938C2
rank
NormalRank
type
BestRank
Statement
P6179
1083804801
http://www.w3.org/2001/XMLSchema#string